The impact of maternal obesity during pregnancy on offspring immunity

Randall M Wilson1, Ilhem Messaoudi2

  • 1Graduate Program in Cell, Molecular, and Developmental Biology, University of California, Riverside, USA.

Insights

Maternal obesity during pregnancy can negatively impact fetal immune system development, potentially leading to chronic health issues in offspring. This review explores how obesity affects neonatal immunity and the underlying mechanisms.

Area of Science:

  • Immunology
  • Developmental Biology
  • Public Health

Background:

  • Maternal obesity affects a significant portion of women of childbearing age in the US.
  • Obesity in pregnancy increases risks for adverse maternal-fetal outcomes.
  • Offspring of obese mothers face higher risks of chronic conditions like cardiovascular disease, diabetes, and asthma later in life.

Purpose of the Study:

  • To review the impact of maternal obesity on the neonatal immune system.
  • To explore potential mechanisms linking maternal obesity to altered offspring immunity.
  • To understand how placental inflammation and nutrient transport may be involved.

Main Methods:

  • This is a review article, synthesizing existing research.
  • It examines data from human studies and rodent models.
  • Focuses on immunological and developmental aspects.

Main Results:

  • Maternal obesity is linked to perturbations in the developing fetal immune system.
  • Increased placental inflammation due to maternal obesity may directly impact neonatal development.
  • Altered nutrient transport across the placenta is a potential mechanism.

Conclusions:

  • Maternal obesity poses a significant risk to neonatal immune system development.
  • Understanding these mechanisms is crucial for preventing long-term offspring health issues.
  • Further research is needed to fully elucidate the complex interactions.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
287
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343